Epidemiological Profile of Meningococcal Disease in the United States
Open Access
- 1 March 2010
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 50 (2), S37-S44
- https://doi.org/10.1086/648963
Abstract
Neisseria meningitidis is a leading cause of bacterial meningitis and other serious infections worldwide. The epidemiological profile of N. meningitidis is highly changeable, with great differences in disease incidence and serogroup distribution. Six serogroups (namely serogroups A, B, C, W-135, X, and Y) are responsible for most cases of meningococcal disease worldwide; the epidemiological profile of disease caused by each serogroup is unique. No vaccine is available for endemic disease caused by serogroup B strains. Two tetravalent (A/C/Y/W-135) meningococcal vaccines are licensed in the United States: a purified polysaccharide product and a polysaccharide-protein conjugate vaccine. The conjugate vaccine is recommended for all adolescents, although vaccine coverage remains low, and other groups at high risk of infection. A comprehensive program to prevent invasive meningococcal disease in the United States will require vaccination of infants; several conjugate vaccines for infants may become available in the near future. Broadly protective vaccines for endemic serogroup B disease are also needed.Keywords
This publication has 92 references indexed in Scilit:
- Summary of notifiable diseases--United States, 2006.2008
- Risk Factors for Meningococcal Disease in Students in Grades 9–12The Pediatric Infectious Disease Journal, 2008
- Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd ImmunityThe Journal of Infectious Diseases, 2008
- A Multivalent Conjugate Vaccine for Prevention of Meningococcal Disease in InfantsJAMA, 2008
- Immunogenicity of a Tetravalent Meningococcal Glycoconjugate Vaccine in InfantsJama-Journal Of The American Medical Association, 2008
- A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infantsVaccine, 2007
- Incidence of Pneumococcal Disease Due to Non–Pneumococcal Conjugate Vaccine (PCV7) Serotypes in the United States during the Era of Widespread PCV7 Vaccination, 1998–2004The Journal of Infectious Diseases, 2007
- The outbreak of meningitis due to Neisseria meningitidis W135 in 2003 in Burkina Faso and the national response: Main lessons learntVaccine, 2007
- Meningococcal Meningitis: Unprecedented Incidence of Serogroup X--Related Cases in 2006 in NigerClinical Infectious Diseases, 2007
- Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccinesFEMS Microbiology Reviews, 2007